← Back to Analyst Consensus 
AEON Buy
AEON Biopharma, Inc.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 1, 2026 | Lake Street | maintain | Buy → Buy | $2 | 47% |
| Aug 14, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 30, 2026 | Lake Street | initiate | — → Buy | $1 | 47% |
| Oct 8, 2025 | Aegis Capital | reiterate | Buy → Buy | $7.2 | — |
| Oct 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Aug 14, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Jul 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| May 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| May 15, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $6 | 44% |
| May 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Apr 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Aug 18, 2023 | HC Wainwright & Co. | initiate | — → Buy | $18 | 44% |
Price Target Trend
Mar 30, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days